Jan 16, 2020 / 05:00PM GMT
Unidentified Analyst -
Hello, everyone. Thank you for joining us. On behalf of JP Morgan team, it's my pleasure to introduce our next speaker, Will Lewis, Chairman and CEO of Insmed. Please note that we will be hosting a Q&A session in the Yorkshire room, down the hall.
With that, I will hand it over to Will. Thank you.
William H. Lewis - Insmed Incorporated - President, CEO & Chairman
Thank you very much, and good morning, everyone. Before we begin, I want to draw your attention to our public filings. I'll be making some forward-looking statements, and these should be placed in the context of those public filings. In addition, I'm very pleased to also draw your attention to our label for our lead product, ARIKAYCE. These are the specific details regarding its conditionally approved use.
Our mission at Insmed is to transform the lives of patients with serious and rare diseases. And we start today's presentation, coming off of what is unquestionably the best year in Insmed's history. 2019 set all kinds of records for us, and 2020 promises to be
Insmed Inc at JPMorgan Healthcare Conference Transcript
Jan 16, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers